U.S. Wireless Telecom Stock News

If you are wondering whether Antero Resources at around US$43.09 is offering fair value or not, it helps to step back and look at what the recent share performance is actually telling you. The stock has returned 5.1% over the last week, 27.3% over the last month and 26.0% year to date, while the 1 year return sits at 5.7% and the 3 year return is 98.4%. Recent coverage has focused on Antero Resources within broader discussions of US energy producers and investor interest in gas focused...

Wondering if Lowe's Companies at around US$224 per share still offers value, or if most of the opportunity is already priced in. The stock is roughly flat over 1 year with a 0.9% return, but that sits alongside a 5.5% decline over the last 7 days and a 20.4% decline over the last 30 days, leaving the year to date return at a 9.0% decline. These recent moves come as investors continue to reassess large U.S. retailers and home improvement names in light of shifting consumer demand and...

Wondering whether Braze at US$18.33 is starting to look like value or still carries too much risk? This article breaks down what the current price may be implying about the company. The stock has been volatile, with a 2.3% decline over the last 7 days, a 6.7% gain over the last 30 days, a 43.7% fall year to date, and a 50.5% decline over the last year. These moves have come as investors continue to reassess higher growth software names, with attention on how quickly companies can balance...

Wondering whether S&P Global at around US$424 per share still offers value, or if the best part of the opportunity has passed, starts with a clear look at what you are paying for its future cash flows. The stock has returned 0.5% over the past week and 1.2% over the past month, but sits on a year to date return of 17.2% decline and a 14.1% decline over the past year, alongside longer term 3 year and 5 year returns of 30.0% and 23.1% respectively. Recent coverage of S&P Global has focused on...

Western Midstream Partners recently raised its Q1 2026 cash distribution to US$0.93 per unit, implying an annualized payout of US$3.72, while also reporting record full-year 2025 adjusted EBITDA and free cash flow despite softer Q4 results. The decision to boost the payout while throughput faces headwinds from reduced drilling underscores management’s confidence in the partnership’s cash generation and capital projects such as the Pathfinder water pipeline and North Loving II processing...

Boone Capital Management has disclosed a significant new position in Tyra Biosciences. The investment comes as Tyra Biosciences advances multiple clinical trials centered on FGFR3 biology. The move highlights fresh institutional interest in NasdaqGS:TYRA at a current share price of $37.15. For readers tracking Tyra Biosciences, the company now sits at a share price of $37.15 with substantial recent share price momentum, including a 26.4% return over the past 30 days and 38.7% year to date...

Planet Labs PBC (PL) has just closed out FY 2026 with fourth quarter revenue of US$86.8 million and a basic EPS loss of US$0.48. Trailing twelve month revenue stood at US$307.7 million and EPS at a loss of US$0.80. Over recent periods, the company has seen quarterly revenue move from US$61.6 million in FY 2025 Q4 to US$66.3 million in FY 2026 Q1, US$73.4 million in Q2, US$81.3 million in Q3 and US$86.8 million in Q4. This has come alongside a sequence of widening quarterly EPS losses from...

Intellicheck (IDN) has rounded out FY 2025 with fourth quarter revenue of about US$6.6 million and basic EPS of roughly US$0.08, alongside trailing twelve month revenue of US$22.7 million and EPS of about US$0.07 that reflect a move into positive net income of around US$1.3 million over the year. The company has seen quarterly revenue progress from US$4.9 million in Q1 2025 to US$6.6 million in Q4 2025, with EPS shifting from a small loss of roughly US$0.02 per share early in the year to a...

Warner Bros. Discovery (NasdaqGS:WBD) has agreed to be acquired by Paramount Skydance in a cash and stock deal valued at $110b. The transaction includes a record-breaking golden parachute package for CEO David Zaslav as part of the change in control. The deal follows a period of awards recognition for Warner Bros.' recent film slate and is expected to reshape competition among major studios. For investors tracking NasdaqGS:WBD, this $110b agreement comes after a very strong 1 year share...

Linde plans to build a new industrial gases facility in Oshkosh, Wisconsin. The project is intended to expand supply capacity for industrial customers across the Midwest. The development marks a further investment in regional infrastructure for NasdaqGS:LIN. Linde, trading on NasdaqGS:LIN, is moving ahead with construction of a new industrial gases facility in Oshkosh, Wisconsin, adding to its US footprint. The company’s shares most recently closed at $488.15, with a return of 13.8% year to...

If you are wondering whether GPGI is attractively priced or already reflecting a lot of optimism, the current share price at US$17.06 raises some useful questions about what you are really paying for. Recent returns are mixed, with the stock up 3.3% over the last week but showing a 27.4% decline over 30 days, an 8.6% decline year to date, and gains of 51.0% over 1 year, 191.8% over 3 years, and 114.8% over 5 years. These moves sit against a backdrop of ongoing coverage that keeps GPGI on...

FDA grants premarket approval to LivaNova's aura6000 System for adult patients with moderate to severe Obstructive Sleep Apnea who do not benefit from standard therapies. The system uses proximal hypoglossal nerve stimulation and is supported by clinical trial data showing meaningful outcomes, including in harder to treat patient groups. LivaNova (NasdaqGS:LIVN) also discloses work on a next generation, MRI compatible version of the aura6000 with additional features. LivaNova, listed on...

Why Sportradar’s latest earnings and deal activity matter for investors Sportradar Group (SRAD) recently reported 2025 earnings, with revenue up 17% to €1,290 million, supported by US growth and a 109% customer net retention rate. The company also closed the IMG ARENA acquisition. The company extended its exclusive data partnership with MLB for 8 years and added new rights with FIFA and the German DFB Cup, expanding coverage to more than 1 million sporting events each year. See our latest...

RCI Hospitality Holdings (RICK) FY 2025 earnings at a glance RCI Hospitality Holdings (RICK) has just posted its FY 2025 numbers with Q4 revenue of US$70.9 million and a basic EPS loss of US$0.63, set against trailing 12 month EPS of US$1.23 on revenue of US$279.4 million and earnings growth of 259.1% for the period. Over recent quarters, revenue has moved from US$73.2 million in Q4 2024 to US$71.5 million in Q1 2025, US$65.9 million in Q2, US$71.1 million in Q3 and US$70.9 million in Q4,...

If you are wondering whether Northern Oil and Gas at around US$28.84 is offering fair value or a potential mismatch between price and underlying worth, you are not alone. The stock has recent returns of 4.8% over 7 days, 5.4% over 30 days, 31.0% year to date and 2.4% over 1 year, which naturally raises questions about how much is already reflected in the price. Recent coverage has focused on Northern Oil and Gas in the context of its role within the broader energy sector and its position as...

In March 2026, Soleno Therapeutics updated its corporate bylaws, continued outreach with a CEO presentation at the Longwood Healthcare Leaders conference, and faced an investor class action lawsuit alleging inadequate disclosure of safety concerns around its Prader‑Willi syndrome therapy DCCR/Vykat XR. This combination of governance changes, legal scrutiny and discussion of a slower Vykat XR launch puts renewed focus on how safety perceptions and patient adoption may shape Soleno’s...

Microvast Holdings (MVST) is back in focus after reaffirming and expanding its long running battery partnership with Iveco Group in Europe, alongside releasing 2025 results, 2026 guidance, and an auditor warning on going concern risks. See our latest analysis for Microvast Holdings. Despite a series of material updates including the expanded Iveco partnership, 2025 results, 2026 guidance and the going concern warning, Microvast’s recent share price performance has been weak. The 30 day share...

If you are wondering whether Viridian Therapeutics at around US$26.98 is offering good value or asking too much, you are in the right place. The stock has recently seen mixed returns, with a 7 day move of 5.9% decline and a 30 day return of 4.0% decline, while still sitting on a 76.8% gain over the past year and 12.1% decline year to date. Recent news coverage has focused on Viridian Therapeutics as a biotech name that continues to attract attention from investors watching the sector. This...

AOP Health’s decision to run its rare disease and intensive care operations on Veeva Systems (VEEV) cloud platforms highlights how deeply Veeva’s software can be embedded across clinical, regulatory, safety, and commercial workflows. See our latest analysis for Veeva Systems. Even with news like the AOP Health rollout highlighting real world use of its platforms, Veeva’s share price tells a mixed story. A 7 day share price return of 2.9% is set against a 1 year total shareholder return...

In recent weeks, oil prices have climbed sharply following the Iran conflict, pushing Brent crude above US$100 per barrel and refocusing attention on efficient US producers such as EOG Resources. The key angle for investors is how EOG’s reputation for low-cost, high-productivity wells may allow it to convert higher prices into additional excess cash to reinvest and return to shareholders. We’ll now examine how this period of elevated oil prices could influence EOG Resources’ existing...

TransMedics Group (TMDX) is drawing attention after a recent share pullback, with reports of insider selling by senior executives and directors coinciding with continued pressure on the stock, despite generally supportive analyst commentary. See our latest analysis for TransMedics Group. The recent weakness in TransMedics Group’s share price, including a 14.28% 1 month share price return decline and a 7.16% negative year to date share price return, sits against a much stronger 64.95% 1 year...

GE Vernova and Hitachi have been selected to supply BWRX-300 small modular reactors for a new US Japan nuclear program. The reactors are planned for deployment in Tennessee and Alabama as part of a wider $40b bilateral investment initiative. The selection positions GE Vernova at the center of a high profile cross border nuclear buildout focused on SMR technology. For investors watching NYSE:GEV, this project ties the company’s nuclear capabilities to a sizeable capital program that goes...

Wondering whether Hewlett Packard Enterprise at around US$21.69 is offering genuine value or just headline appeal? This article breaks down what the current price might be implying about the business. The stock has recent returns of 0.5% over 7 days and 0.6% over 30 days, set against a year to date return of a 10.3% decline, and gains of 37.7% over 1 year, 64.4% over 3 years and 55.8% over 5 years. Recent coverage of Hewlett Packard Enterprise has focused on how investors are reassessing...

Wondering whether Bob's Discount Furniture is a bargain or a value trap at around US$12.49? This article breaks down what the current price might be implying about the business. The stock has seen sharp recent moves, with a 7 day return of an 18.9% decline and a 30 day return of a 37.2% decline, while the year to date return sits at a 26.6% decline. These swings have put Bob's Discount Furniture back on the radar for investors who are reassessing what they are willing to pay for retailers...